Emerging Immunotherapy Approaches for Treating Prostate Cancer

被引:11
|
作者
Meng, Lingbin [1 ]
Yang, Yuanquan [1 ]
Mortazavi, Amir [1 ]
Zhang, Jingsong [2 ]
机构
[1] Ohio State Univ, Comprehens Canc Ctr, Dept Internal Med, Div Med Oncol, Columbus, OH 43210 USA
[2] Univ S Florida, H Lee Moffitt Canc Ctr & Res Inst, Dept Genitourinary Oncol, 12902 USF Magnolia Dr, Tampa, FL 33612 USA
关键词
immunotherapy; prostate cancer; immune checkpoint inhibitors; bispecific antibodies; CAR T cells; vaccines; cytokines; immunotherapeutic combinations; CAR-T-CELLS; IMMUNE-CHECKPOINT; DOUBLE-BLIND; PHASE-III; PLUS DOCETAXEL; CLINICAL-TRIAL; SIPULEUCEL-T; TUMOR MICROENVIRONMENT; DNA VACCINE; ANTIGEN;
D O I
10.3390/ijms241814347
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Immunotherapy has emerged as an important approach for cancer treatment, but its clinical efficacy has been limited in prostate cancer compared to other malignancies. This review summarizes key immunotherapy strategies under evaluation for prostate cancer, including immune checkpoint inhibitors, bispecific T cell-engaging antibodies, chimeric antigen receptor (CAR) T cells, therapeutic vaccines, and cytokines. For each modality, the rationale stemming from preclinical studies is discussed along with outcomes from completed clinical trials and strategies to improve clinical efficacy that are being tested in ongoing clinical trials. Imperative endeavors include biomarker discovery for patient selection, deciphering resistance mechanisms, refining cellular therapies such as CAR T cells, and early-stage intervention were reviewed. These ongoing efforts instill optimism that immunotherapy may eventually deliver significant clinical benefits and expand treatment options for patients with advanced prostate cancer.
引用
收藏
页数:26
相关论文
共 50 条
  • [11] Immunotherapy in Prostate Cancer
    Sobol, Ilya
    Thompson, R. H.
    Dong, Haidong
    Krco, Christopher
    Kwon, Eugene D.
    CURRENT UROLOGY REPORTS, 2015, 16 (06) : 1 - 5
  • [12] Immunotherapy for Prostate Cancer: A Current Systematic Review and Patient Centric Perspectives
    Rehman, Laeeq ur
    Nisar, Muhammad Hassan
    Fatima, Wajeeha
    Sarfraz, Azza
    Azeem, Nishwa
    Sarfraz, Zouina
    Robles-Velasco, Karla
    Cherrez-Ojeda, Ivan
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (04)
  • [13] Immunotherapy in prostate cancer: Emerging strategies against a formidable foe
    Bilusic, Marijo
    Heery, Christopher
    Madan, Ravi A.
    VACCINE, 2011, 29 (38) : 6485 - 6497
  • [14] Immunotherapy for Prostate Cancer: Treatments for the "Lethal" Phenotype
    Slovin, Susan F.
    UROLOGIC CLINICS OF NORTH AMERICA, 2020, 47 (04) : 469 - 474
  • [15] Current and emerging trends in prostate cancer immunotherapy
    Schatz, Adam
    Mian, Badar M.
    ASIAN JOURNAL OF ANDROLOGY, 2019, 21 (01): : 6 - 11
  • [16] New approaches and prospects of immunotherapy and gene therapy for prostate cancer
    Bibi, Roshni
    Sarkar, Koustav
    JOURNAL OF TRANSLATIONAL GENETICS AND GENOMICS, 2024, 8 (02) : 119 - 161
  • [17] Promising immunotherapy for prostate cancer
    Henegan, John C.
    Sonpavde, Guru
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2018, 18 (02) : 109 - 120
  • [18] Prostate Cancer Immunotherapy-Finally in From the Cold?
    Runcie, Karie D.
    Dallos, Matthew C.
    CURRENT ONCOLOGY REPORTS, 2021, 23 (08)
  • [19] Beyond Sipuleucel-T: Immune Approaches to Treating Prostate Cancer
    Michael L. Cheng
    Lawrence Fong
    Current Treatment Options in Oncology, 2014, 15 : 115 - 126
  • [20] Clinical development of immunotherapy for prostate cancer
    Noguchi, Masanori
    Koga, Noriko
    Igawa, Tsukasa
    Itoh, Kyogo
    INTERNATIONAL JOURNAL OF UROLOGY, 2017, 24 (09) : 675 - 680